Spear Bio Inc. raised $45M in a Series A financing co-led by Foresite Capital and Bio-Techne Corporation to accelerate the launch of protein research and disease diagnostics products.

Jul 29, 2024•over 1 year ago

Amount Raised

$45 Million

Round Type

series a

WoburnBiotechnology

Investors

Cdh InvestmentsYonjin CapitalMaverick VenturesBio Techne CorporationForesite Capital

Description

Spear Bio Inc. announced the successful closing of its $45 million Series A financing, aimed at advancing their innovative protein measurement technology. The round was oversubscribed and included participation from notable investors including Maverick Ventures and Yonjin Capital.

Company Information

Company

Spear Bio

Location

Woburn, Massachusetts, United States

About

Spear Bio – founded in 2021 and headquartered in Woburn, Massachusetts – is an innovative leader in providing scalable solutions for ultra-sensitive protein biomarker measurements. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar level from sub-microliter sample volume. Spear Bio is focused on leveraging its technology’s unprecedented sensitivity to transform protein research and early disease diagnosis.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends